Neurolytixs
Neurolytixs provides a fast, blood-based method to identify concussions so sports teams and clinicians can make informed care decisions quickly. The company combines blood biomarker assays with machine learning and artificial intelligence to detect brain-derived signals associated with concussion. It operates as a biotechnology diagnostic and health-technology provider serving sports organizations, clinics, and other B2B customers. Neurolytixs targets the sports market—particularly on-site and youth amateur settings—where rapid, objective concussion assessment is needed.
Neurolytixs
Neurolytixs provides a fast, blood-based method to identify concussions so sports teams and clinicians can make informed care decisions quickly. The company combines blood biomarker assays with machine learning and artificial intelligence to detect brain-derived signals associated with concussion. It operates as a biotechnology diagnostic and health-technology provider serving sports organizations, clinics, and other B2B customers. Neurolytixs targets the sports market—particularly on-site and youth amateur settings—where rapid, objective concussion assessment is needed.